APA Alıntı

Carter, A. W. (2014). FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell? J Diabetes Sci Technol.

Chicago Stili Alıntı

Carter, Alan W. "FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell?" J Diabetes Sci Technol 2014.

MLA Alıntı

Carter, Alan W. "FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell?" J Diabetes Sci Technol 2014.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..